The successful treatment for children with hematological disorders nowadays has greatly increased the survival rates for these young people compared to children diagnosed with hematological malignancies in the past. However, more than half of survivors will exhibit at least one long-term complication that will impair quality of life (QoL). Furthermore, the fatigue, frequent pain and aches these patients experience have a negative impact on QoL.
Objective
The objective of this study was to investigate QoL in our series of children with haematological disorders that were referred for endocrine evaluation to the Department of Endocrinology at Elias University Hospital from the Department of Pediatric Bone Marrow Transplantation Unit in Fundeni Hospital.
Material and Method
QoL was assessed in 26 patients with hematological disease using two survey instruments, one used for children with various chronic pediatric disorders (PedQL) [1] and one that was validated for cancer survivors (SF-36) [2]. The results were compared to QoL scores from 11 children with endocrine disorders that were evaluated in our clinic and had no hematological disease (control group).
Results
No statistically significant differences were found in the QoL between the two groups of patients in our study. Furthermore, QoL in survivors of childhood onset hematological disease was not influenced by the type of complications they developed in the long-term follow-up, chronic use of glucocorticoids or gender [3,4,5]. One possible explanation could be the small number of patients enrolled in the present study. Moreover, the presence of endocrine disease in both groups may be a confounder having in mind that a significant number of patients with hematological disorders develop endocrinopathies as a consequence of treatment (chemotherapy, radiotherapy, immunotherapy or following conditioning for hematopoietic stem cell transplantation) or the disease itself.
Conclusions
Even if our study failed to demonstrate an impaired QoL in survivors of pediatric hematological disease, the descriptive data provided by this paper present an important degree of novelty for the Romanian medical literature, having the potential to serve as a theoretical basis for future extensive studies with a similar topic.
Funding
This research received no external funding.
Conflicts of Interest
The authors declare no conflict of interest.
ReferencesDesaiA.D.ZhouC.StanfordS.HaalandW.VarniJ.W.Mangione-SmithR.M.Validity and Responsiveness of the Pediatric Quality of Life Inventory (PedsQL) 4.0 Generic Core Scales in the Pediatric Inpatient Setting2014168111425347549ReulenR.C.ZeegersM.P.JenkinsonC.LancashireE.R.WinterD.L.JenneyM.E.HawkinsM.M.The use of the SF-36 questionnaire in adult survivors of childhood cancer: Evaluation of data quality, score reliability, and scaling assumptions200610.1186/1477-7525-4-7717022814SztankayM.GiesingerJ.HolznerB.Gender differences in quality of life in patients with haematological malignancies201110.1007/s12254-011-0299-7ValassiE.FeeldersR.MaiterD.ChansonP.YanevaM.ReinckeM.KrsekM.TóthM.WebbS.M.SantosA.Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing’s disease than patients with cortisol producing adenoma. Data from the ERCUSYN201810.1111/cen.1360029574994De JongM.TammingaS.J.van EsR.J.J.Frings-DresenM.H.W.de BoerA.G.E.M.The quality of working life questionnaire for cancer survivors (QWLQ-CS): Factorial structure, internal consistency, construct validity and reproducibility20181810.1186/s12885-017-3966-129321006